We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

231 hedge funds and large institutions have $2.61B invested in Axsome Therapeutics in 2023 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 90 increasing their positions, 54 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 16

75% more call options, than puts

Call options by funds: $106M | Put options by funds: $60.5M

67% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 54

33% more capital invested

Capital invested by funds: $1.97B → $2.61B (+$647M)

17% more funds holding

Funds holding: 197 → 231 (+34)

4.83% more ownership

Funds ownership: 73.31% → 78.14% (+4.8%)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

Holders
231
Holders Change
+34
Holders Change %
+17.26%
% of All Funds
3.63%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.13%
New
50
Increased
90
Reduced
54
Closed
16
Calls
$106M
Puts
$60.5M
Net Calls
+$45.1M
Net Calls Change
+$22.7M

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$73.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$56.4M
3
RI
RTW Investments
New York
+$37.1M
4
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$34M
5
DTC
Deep Track Capital
Connecticut
+$28.3M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$51.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$44.7M
3
Holocene Advisors
Holocene Advisors
New York
-$32.6M
4
Millennium Management
Millennium Management
New York
-$22.4M
5
WP
Woodline Partners
California
-$9.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
BWP
76
Baldwin Wealth Partners
Massachusetts
$3.45M +$36.9K +500 +1%
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
$3.36M +$194K +2,633 +6%
Macquarie Group
78
Macquarie Group
Australia
$3.31M +$1.93M +26,187 +132%
Principal Financial Group
79
Principal Financial Group
Iowa
$3.13M +$2.49M +33,821 +348%
California State Teachers Retirement System (CalSTRS)
80
California State Teachers Retirement System (CalSTRS)
California
$2.99M +$76.9K +1,042 +3%
AllianceBernstein
81
AllianceBernstein
Tennessee
$2.92M – – –
RPAM
82
Rhenman & Partners Asset Management
Sweden
$2.88M +$1.85M +25,100 +167%
ACM
83
Altium Capital Management
New York
$2.87M +$2.95M +40,000 New
MOACM
84
Mutual of America Capital Management
New York
$2.75M -$216K -2,925 -7%
State of Wisconsin Investment Board
85
State of Wisconsin Investment Board
Wisconsin
$2.75M +$638K +8,649 +29%
MS
86
Maven Securities
Jersey
$2.52M +$2.58M +35,000 New
SFG
87
SVB Financial Group
Texas
$2.43M – – –
LCG
88
Lisanti Capital Growth
New York
$2.39M +$2.46M +33,325 New
Legal & General Group
89
Legal & General Group
United Kingdom
$2.39M +$197K +2,676 +9%
State of New Jersey Common Pension Fund D
90
State of New Jersey Common Pension Fund D
New Jersey
$2.33M -$340K -4,606 -12%
AA
91
ALPS Advisors
Colorado
$2.3M +$247K +3,353 +12%
Tudor Investment Corp
92
Tudor Investment Corp
Connecticut
$2.18M +$476K +6,453 +27%
Group One Trading
93
Group One Trading
Illinois
$2.17M +$1.73M +23,473 +351%
DekaBank Deutsche Girozentrale
94
DekaBank Deutsche Girozentrale
Germany
$2.13M – – –
Ameriprise
95
Ameriprise
Minnesota
$2.13M +$1.66M +22,565 +318%
VF
96
Virtu Financial
New York
$2.13M +$1.73M +23,508 +387%
Bank of America
97
Bank of America
North Carolina
$2.09M -$259K -3,517 -11%
Wells Fargo
98
Wells Fargo
California
$2.04M -$2.79M -37,878 -57%
Carson Wealth (CWM LLC)
99
Carson Wealth (CWM LLC)
Nebraska
$2.01M +$2.07M +27,996 +93,320%
UOC
100
UBS O'Connor
Illinois
$1.85M +$234K +3,169 +14%
2 3
4
5 6

AXSM Hedge Fund Activity: Q2 2023 in Review

231 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q2 2023, worth a combined $2.61B — up 33% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new AXSM positions and 16 closed out — a net gain of 34 holders — while 90 added to existing stakes and 54 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $73.8M. The largest seller was Point72 Asset Management, cutting an estimated $51.8M.

  • 231 institutional investors held Axsome Therapeutics (AXSM) as of Q2 2023, up from 197 in Q1 2023.
  • Funds reported $2.61B of Axsome Therapeutics stock for Q2 2023, up 33% quarter-over-quarter.
  • 50 funds opened new Axsome Therapeutics positions in Q2 2023 and 16 closed out, a net change of +34 holders.
  • The largest Axsome Therapeutics buyer in Q2 2023 was RA Capital Management, an estimated $73.8M added.
  • The largest Axsome Therapeutics seller in Q2 2023 was Point72 Asset Management, an estimated $51.8M sold.

Based on aggregated 13F filings for Q2 2023.